Natus to Present at J.P. Morgan 31st Annual Healthcare Conference
- Webcast Available on Company Web Site
SAN CARLOS, Calif.--(BUSINESS WIRE)-- Natus Medical Incorporated (NAS: BABY) today announced that Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the J.P. Morgan 31st Annual Healthcare Conference. The conference is being held at the Westin St. Francis Hotel in San Francisco on January 6-10, 2013. Mr. Hawkins is scheduled to present at 12:30 p.m. Pacific Time (3:30 p.m. ET) on Thursday, January 10, 2013. Attendance at the J.P. Morgan 30th Annual Healthcare Conference is by invitation only.
Investors may listen to a live webcast and view a copy of the slide presentation online via the "Investors" section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days.
About Natus Medical
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.
Additional information about Natus Medical can be found at www.natus.com.
Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
Vice President Finance and Chief Financial Officer
KEYWORDS: United States North America California
The article Natus to Present at J.P. Morgan 31st Annual Healthcare Conference originally appeared on Fool.com.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.